final action
on 08 Mar 2024
Last Applicant/ Owned by
2000 Sierra Point Parkway, Suite 501
Brisbane
CA
94005
Serial Number
98191847 filed on 21st Sep 2023
Registration Number
N/A
Correspondent Address
CONNIE L. ELLERBACH
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Research, development, and product evaluation of pharmaceutical preparations for the prevention and treatment of cancer; laboratory analysis and research of drugs and pharmaceutical products; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; research and development services in the fields of oncology, immunotherapy, chemotherapRead More
Providing clinical information and support services regarding prescription drugs and treatment of disease; healthcare services, namely, wellness and disease management programs; providing medical information regarding the treatment, and diagnosis of diseases; providing medical information regarding pharmaceutical products for the treatment of diseases; providing medical information and advice for healthcare service providers and patients in connection with pharmaceutical product treatment; healthcare patient support services by means of a call center; providing patient support services, namely, providing patient check-up services in the form of reminders, wellness trackers, and patient and caregiver wellness check-ups; providing patient support services, namely, connecting patients and their families with outside foundations and organizations, advocacy groups, and other patient support groups; medical information services; healthcare services; research, development, and evaluation of pharmaceutical preparations for the prevention and treatment of cancer; laboratory analysis and research of drugs and pharmaceutical products; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; healthcare services, namely, providing cancer treatment information to physicians, health care professionals, and patients; design, development, research, and testing of drugs and pharmaceuticals for the treatment and/or prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical information services, namely, providing information regarding viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; providing a website featuring health information in the field of tumors and cancer; providing a website featuring health information in the field of pediatric low-grade glioma; providing medical information regarding the treatment and diagnosis of tumors and cancer; providing medical information regarding the treatment and diagnosis of pediatric low-grade glioma; providing medical information and health advice for healthcare service providers, caregivers, and patients in connection with tumors and cancer; providing medical information and health advice for healthcare service providers, caregivers, and patients in connection with pediatric low-grade glioma; medical information services regarding tumors and cancer, and pediatric low-grade glioma
Research, development, and product evaluation of pharmaceutical preparations for the prevention and treatment of cancer; laboratory analysis and research of drugs and pharmaceutical products; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; design, development, research, and testing of new products, namely, drugs and pharmaceuticals for the treatment and/or prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system diseases and disorders
Educational services, namely, providing information regarding the treatment, and diagnosis of diseases; educational services, namely, providing training regarding the treatment, and diagnosis of diseases; educational services, namely, providing prescription drug information; educational services, namely, providing prescription drug dosage training; educational services, namely, providing online non-downloadable videos in the field of treatment and diagnosis of tumors and cancer; educational services, namely, providing online non-downloadable videos in the field of treatment and diagnosis of pediatric low-grade glioma; educational services, namely, providing online non-downloadable videos for healthcare service providers, caregivers, and patients in the field of tumors and cancer; educational services, namely, providing online non-downloadable videos for healthcare service providers, caregivers, and patients in the field of pediatric low-grade glioma; providing information regarding tumors and cancer, and pediatric low-grade glioma
Healthcare insurance administration services; healthcare insurance administration services, namely, providing benefit verification, authorization and re-authorization support, appeals support, and information regarding benefit updates; providing information about healthcare insurance plans; business administration services, namely, providing patient reimbursement programs; financial services, namely, assessing sources of and facilitating access by patients and their families to financial support from copay support, patient assistance programs (PAP), patient foundations and organizations; financial services, namely, administration of patient reimbursement programs
Pharmaceutical preparations; pharmaceutical preparations for human use; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; targeted medical preparations for use in the field of cancer prevention and treatment; medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
No 98191847
No Service Mark
No 37942-00070
No
No
No
No
No
No
No
No
01.05.01 -
Sun, rising or setting (partially exposed or partially obstructed)
The mark consists of the words DAY ONE above the word BIOPHARMACEUTICALS with sun rays emanating from and above the "e" at the end of the word ONE.
| Status Date | Action Taken |
|---|---|
| 08th Mar 2024 | NON-FINAL ACTION WRITTEN |
| 08th Mar 2024 | NON-FINAL ACTION E-MAILED |
| 08th Mar 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 27th Feb 2024 | ASSIGNED TO EXAMINER |
| 10th Oct 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| 09th Oct 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 25th Sep 2023 | NEW APPLICATION ENTERED |
